Aster DM Healthcare's shares experienced a significant surge, climbing up to 5% intraday, following the announcement of a definitive agreement to merge with Blackstone-backed Quality Care India Limited (QCI), which is expected to position the combined entity as one of India's top three hospital chains.
Merger Details:
Last week, Aster DM Healthcare and Quality Care India, backed by Blackstone, announced a strategic merger through a share swap deal. This merger will create a healthcare giant with a network of 38 hospitals and over 10,150 beds across 27 cities, positioning the combined entity as one of India's top three hospital chains. Before the merger, Aster DM Healthcare will acquire a 5% stake in Quality Care India from its private equity shareholders through a preferential equity issue, valuing Aster DM Healthcare's shares at INR 456. Post-merger, Aster DM Healthcare shareholders will hold a 57.3% stake, while Quality Care India shareholders will retain 42.7%. This merger is expected to unlock significant operational synergies, accelerate growth, and enhance patient care.
Aster DM Healthcare Share Price Movement:
Aster DM Healthcare shares experienced a positive start this morning, with the positive sentiment in the market surrounding its merger with QCIL. The stock opened at Rs. 507.50 and reached an intraday high of Rs. 524.65 before slightly dipping by 0.16% to Rs. 499.15 by 1:00 pm. In the past week, Aster DM's stock surged 13.47%, showing strong momentum. Similarly, the stock saw a 13.08% rise in November, following a period of flat trading. The past six months have been profitable for investors, with the stock increasing by 39.96%. Additionally, year-to-date growth stands at 23%, and the stock has gained 24% over the past year. Over the last five years, Aster DM Healthcare has experienced remarkable growth, with a massive 219% increase in its stock price. This long-term performance highlights the company's strong market presence and investor confidence, driven by both its growth trajectory and future merger prospects.
Financial Reports
As per the financial data compiled by Elara Securities, disclosed by both companies, Quality Care India (QCI) reported a revenue of INR 36.2 billion and an adjusted EBITDA of INR 7.8 billion in the fiscal year 2024. Additionally, QCI achieved an impressive adjusted Return on Capital Employed (ROCE) of 20%. In comparison, Aster DM Healthcare generated a revenue of INR 37.0 billion and an EBITDA of INR 5.8 billion in the same fiscal year. Notably, Aster DM Healthcare has witnessed significant growth, with its EBITDA increasing by over 40% year-over-year in the first half of the current fiscal year.
About Aster DM Healthcare
Founded in 1987 by Dr. Azad Moopen, Aster DM Healthcare is a leading public healthcare provider. The company is headquartered in Dubai, UAE, and is registered in Bengaluru, India. Aster offers high-quality healthcare services and operates a range of healthcare facilities across the region.
About Quality Care India (QCI)
QCI, an unlisted hospital network, is backed by major stakeholders such as Blackstone and TPG. It operates 26 healthcare centers with over 5,150 beds in 14 cities. Key regions for QCI include Kerala, Telangana, and Bangladesh, where it plays a significant role in the healthcare industry.
Click it and Unblock the Notifications
Sign in with Google